EEG Biomarkers for ADHD Stimulant Treatment | MicrobiomeTrials← Back to trialsNCT07650643
EEG Biomarkers for ADHD Stimulant Treatment
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-09-15Est. Completion: 2031-05-30
Enrollment target: 220 participants Locations- Boston Children's Hospital at Two Brookline Place, Brookline, Massachusetts, United States
Other microbiome trials you might be interested in
FibromyalgiaChronic Pain SyndromeMuscle ThinningSleepVitamin D3
Fibromyalgia syndrome (FMS) is a chronic disease characterized by widespread body pain and tenderness in specific points…
Kırşehir, Turkey (Türkiye)Completed Jan 25, 2025
Autism Spectrum Disorder (ASD)
It is well documented that motor impairments are associated with a diagnosis of autism spectrum disorder (ASD). Yet, app…
New York, United StatesCompleted May 23, 2026